Exiqon A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Exiqon A/S with three other
miscellaneous service companies in Europe:
sales of 22.51 million Euro [US$24.50 million]
Brain Biotechnology Research and Information Network AG
(23.92 million Euro [US$26.03 million]
of which 0%
was BioIndustrial), and
Zealand Pharma A/S
(187.68 million Danish Kroner [US$27.45 million]
of which 100%
During the year ended December of 2015, sales at
Exiqon A/S were 162.02 million Danish Kroner (US$23.70 million).
increase of 22.4%
versus 2014, when the company's sales were 132.39 million Danish Kroner.
This was the fifth consecutive year of sales increases at Exiqon A/S
(and since 2010, sales have increased a total of 73%).
Sales of Life Sciences saw an increase
that was more than double the company's growth rate: sales were up
49.7% in 2015, from
131.19 million Danish Kroner to 196.45 million Danish Kroner.
Not all segments of Exiqon A/S experienced an increase in sales in 2015:
sales of Diagnostics fell 1.8% to 3.26 million Danish Kroner.
(However, this segment's sales were only a very small portion of the company's overall sales).